Desenvolvimento, caracterização e avaliação de atividade antimicrobiana in vitro de microemulsão contendo derivado tiofênico para administração oral

Abstract

Microemulsions (MEs) are isotropic and thermodynamically stable systems translucent two immiscible liquids, usually water and oil, stabilized by an interfacial film of surfactants located at the oil / water interface. The thiophenes and its derivatives are an important class of heterocyclic compounds having a wide variety of biological properties including antibacterial, antifungal, analgesic, anti-inflammatory, antioxidant. In this study 2 - [(2,4-dichloro-benzylidene)-amino]-5,6-dihydro-4H- cyclopenta [b] thiophene-3-carbonitrile was utilized, called 5CN06. The objective of this research was to develop, characterize and evaluate the in vitro antifungal activity of microemulsion for oral use containing a thiophene derivative. A pseudo-ternary phase diagram (PTPD) was constructed adopting a high energy approach using labrasol (LAS) as surfactant, Ethanol (EtOH) as co-surfactant, isopropyl myristate (IPM) as oil phase and water as aqueous phase. Proportions defined of LAS, IPM and EtOH were titrated with water and the appearance observed at each point of DFPT and the ME regions were highlighted. The blank ME (ME B) was obtained from a selected point in DFPT, at this point it was evaluated the incorporation of 5CN06 by three different methods (M1, M2 and M3). All formulations were characterized and evaluated for macroscopic aspects, entrapment efficiency, droplet size and polydispersity index (PDI), polarized light microscopy, differential scanning calorimetry (DSC), X-ray diffraction (XRD) and in vitro antimicrobial activity. A spectrophotometric analytical method was developed and validated to quantify the 5CN06 in MEs. The technique employed for the construction of PTPD proved quite simple and reproducible. The MEs maintained clarity, transparency and isotropy after incorporation of 5CN06. Blank ME (ME B) and three incorporated ME (ME M1, ME M2 and ME M3) showed droplets sizes with diameter of 24.8 ± 0.5 nm, 25.5 ± 0.42 nm, 24.3 ± 0.43 nm and 29.7 ± 2.5 nm with PDI of 0.371 ± 0.013, 0.377 ± 0.009, 0.362 ± 0.020 and 0.354 ± 0.013 and 5CN06 entrapment of 84%, 86% and 88%, respectively. The MEs formulations were physically stable by storage for 30 days under stress conditions. The analytical method developed and validated showed simple, fast and with minimal cost being considered linear, specific, accurate and precise and therefore validated according the International Conference on Harmonization (ICH) and National Health Surveillance Agency (ANVISA). Previously the antimicrobial activity assay, the 5CN06 was quantified in MEs systems and the results showed that the concentration of 5CN06 was 57, 117,5 and 133,1 for ME M1, ME M2 and ME M3, respectively. ME M2 and M3 showed higher concentration and it were utilized for further studies. Antimicrobial activity of ME M2 and M3 was -1 evaluated and minimal inhibitory concentration (MIC) of 29.4 μg.ml to -1 Staphylococcus aureus and 3.7 μg.ml for both yeasts C. tropicalis e C. parapsilosis -1 were obtained for ME M2. To ME M3 were obtained MIC of 66.6 μg.ml for both -1 strains, Staphylococcus aureus e Escherichia coli and 4.2 μg.ml for Candida albicans, C. tropicalis e C. guillermondii. This preliminary data indicate the potential of MEs for oral delivery of poor aqueous solubility drugs.